Skip to main content
. 2017 May 2;8(32):52901–52912. doi: 10.18632/oncotarget.17548

Figure 3. EMT induction by TGF-β is resistant to vincristine.

Figure 3

(A) Western blot analysis showed that TGF-β induction resulted in EMT and exhibited a loss of E-cadherin and a gain in vimentin expression. (B) EMT acquisition by TGF-β induction was characterized by immunofluorescence. (C) TGF-β-treated cells increased the invasion capacity in the transwell assays. (D) The drug sensitivity of the TGF-β-treated cells decreased compared with that of the parental cells. (E) TGF-β-treated cells failed to exhibit the apoptotic characteristics of caspase-3/7 activation after vincristine exposure. (F) Western blot analysis showed the effect of vincristine (Vin: 80 nM) on PARP cleavage.